|
Market Closed –
|
5-day change | 1st Jan Change | ||
|
3.060 USD |
-6.13% | -19.11% | -63.45% | |
Published on 05/21/2025 at 17:59
This article is reserved for members Unlock the article: REGISTER NOW!
© MT Newswires – 2025
|
Longevity Health Shares Surge After Nasdaq Allows Continued Listing |
May. 21 |
MT |
|
Longevity Health Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 |
May. 15 |
CI |
|
Longevity Health Holdings Announces Reverse Stock Split |
May. 12 |
RE |
|
Longevity Health Holdings Announces Execution Of Merger Agreement With 20/20 Biolabs |
Apr. 14 |
RE |
|
Longevity Health Holdings Executes Merger Agreement With 20/20 BioLabs, Shares Surge |
Apr. 14 |
MT |
|
20/20 GeneSystems, Inc. entered into an Agreement and Plan of Merger to acquire Longevity Health Holdings, Inc. (NasdaqCM: XAGE) for approximately $50 million in a reverse merger transaction. |
Apr. 13 |
CI |
|
Longevity Health Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 |
Mar. 31 |
CI |
|
Longevity Health Holdings, Inc. Auditor Raises ‘Going Concern’ Doubt |
Mar. 30 |
CI |
|
Carmell Corporation Expects to Launch New Products in the Second Quarter of 2025 |
Mar. 10 |
CI |
|
Carmell Corporation has Changed its Name to Longevity Health Holdings, Inc |
Mar. 10 |
CI |
|
Longevity Health Holdings, Inc. Appoints Patrick Sturgeon as Vice Chairman |
Mar. 09 |
CI |
|
Longevity Health Holdings, Inc. Provides Earnings Guidance for the Fiscal Year 2025 |
Mar. 09 |
CI |
|
Carmell Corporation(NasdaqCM:XAGE) dropped from NASDAQ Composite Index |
Mar. 06 |
CI |
|
Carmell Corp Files For Mixed Shelf Of Up To $100 Million |
Feb. 03 |
RE |
|
Carmell Corporation Announces CEO Changes |
Jan. 24 |
CI |
|
Carmell Closes $1.9 Million Private Placement; Shares Tumble Pre-Bell |
Jan. 03 |
MT |
|
Carmell Corporation announced that it has received $1.854998 million in funding |
Jan. 02 |
CI |
|
Top Midday Gainers |
Jan. 02 |
MT |
|
Sector Update: Consumer Stocks Rise Pre-Bell Thursday |
Jan. 02 |
MT |
|
Sector Update: Consumer |
Jan. 02 |
MT |
|
Carmell Signs Agreement to Acquire Elevai’s Skincare, Haircare Assets |
Jan. 02 |
MT |
|
Carmell Corporation signed a definitive purchase agreement to acquire Skincare and haircare business of Elevai Skincare Inc. for $1.2 million. |
Jan. 01 |
CI |
|
Carmell Expects to Raise $1.85 Million From Private Placement |
Dec. 24 |
MT |
|
Carmell Corporation announced that it expects to receive $1.854998 million in funding |
Dec. 22 |
CI |
|
Longevity Health Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 |
Nov. 14 |
CI |
XAGE: Dynamic Chart
Carmell Corporation (Carmell) is a bio-aesthetics company focused on skin and hair health. The Company utilizes the Carmell Secretome to support skin and hair health. The Carmell Secretome consists of a potent cocktail of growth factors and proteins extracted from allogeneic human platelets sourced from United States Food and Drug Administration-approved tissue banks. The Company has developed a novel micellar nanoparticle formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the harmful excipients that are used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. Additionally, Carmell’s micellar formulations do not utilize mineral or vegetable oils across their entire product line and are designed to be non-comedogenic. The Company is also developing a line of men’s products and a line of topical haircare products.
More about the company
Select your edition
All financial news and data tailored to specific country editions
